[Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus].
The authors presented the results of a study of human insulin drugs Monotard HM and Actrapid HM (Novo, Denmark) for type I diabetes mellitus. They stressed their efficacy in therapy of insulin dependent diabetes mellitus: a course of disease became less labile, the time of achieving compensation was reduced; the drugs proved to be effective in the treatment of post-injection insulinlipodystrophies, in body mass deficiency; a tendency to a decrease in daily insulin requirement, serum insulin binding capacity, and in increase in the content of free insulin were noted.